Factor Bioscience and Eterna Therapeutics Partner to Accelerate Advanced Cell Therapies for Cancer, Rare Diseases, and Autoimmune Disorders
In a groundbreaking collaboration that promises to reshape the future of medicine, Factor Bioscience and Eterna Therapeutics have announced an exclusive license agreement to accelerate the development of stem cell-based therapies for oncology, autoimmune disorders, and rare diseases. The agreement is centered around the utilization of Factor’s proprietary induced pluripotent stem cell (iPSC) technologies, which […]